The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHalma Regulatory News (HLMA)

Share Price Information for Halma (HLMA)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2,219.00
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 2.00 (0.09%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 2,219.00
HLMA Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading update

23 Sep 2020 07:00

RNS Number : 7856Z
Halma PLC
23 September 2020
 

Halma plc

Trading update

23 September 2020

 

Halma today releases its scheduled trading update, for the period from 1 April 2020 to date, and confirmation of a management appointment to its Executive Board.

 

Halma has delivered a resilient performance during the period in line with the Board's expectations and, despite the operational challenges arising from the Covid-19 pandemic, the Group has continued to benefit from the long-term growth drivers in its markets, the breadth of its portfolio and the agility of its business model.

 

At the end of the first quarter we reported that revenue was 13% lower than last year on an organic constant currency basis. Since then, the Group's revenue trends have gradually improved, while continued control of costs and working capital have protected profit and ensured good cash generation. Order intake was ahead of revenue albeit marginally down on the same period last year. Given the evolving and uncertain situation in our major markets, the Board continues to expect Adjusted profit before tax (note 1) for FY2021 to be 5%-10% below FY2020 and more weighted to the second half than in previous years.

 

There has continued to be a significant variation in demand in individual end-markets and geographic regions. The USA and Mainland Europe regions have delivered the most resilient overall trading performances. The UK and Asia Pacific have remained more challenging, although the latter has benefited from prior year acquisitions and a gradual recovery in China.

 

The Environmental & Analysis sector has performed well, and the Medical sector has started to see a modest improvement in demand for products related to elective surgical and diagnostic procedures. The Safety sectors were impacted by limitations of physical access to sites in the first quarter, however this has steadily improved during the second quarter to date.

 

The currency translation effect on the Group's results in the first half of the year is expected to be broadly neutral.

 

The Group's financial position remains robust, with committed facilities totalling approximately £750 million at current exchange rates. The earliest maturity in these facilities is for £73 million in January 2021, with the remaining maturities from 2023 onwards. Our sector M&A teams have been actively cultivating opportunities, and the Group continues to see a healthy acquisition pipeline for the future.

 

The results for the half year ending 30 September 2020 will be released on 19 November 2020.

 

New Group General Counsel and Executive Board member

On 14th September 2020, Funmi Adegoke joined Halma as our Group General Counsel. Funmi will continue our work to maintain a strong legal and compliance capability to support the Group's growth, including oversight of our Company Secretariat activities.

 

Before joining Halma, Funmi spent nine years at BP in various roles, most recently as Managing Counsel for BP's Downstream Commercial Development and Transformation business. Prior to BP, Funmi held senior legal and commercial roles with Bombardier. Funmi is a qualified Barrister and holds a law degree from the University of Cambridge. She is a Non-Executive Director of Melrose Industries plc.

 

 

For further information, please contact:

 

Halma plc

Marc Ronchetti, Chief Financial Officer

+44 (0)1494 721111

 

MHP Communications

Rachel Hirst/ Giles Robinson

+44 (0)20 3128 8788

 

About Halma

Halma is a global group of life-saving technology companies, focused on growing a safer, cleaner, healthier future for everyone, every day. Our innovative products and solutions address many of the key issues facing the world today. We operate in four sectors: Process Safety, Infrastructure Safety, Medical and Environmental & Analysis. We employ over 7,000 people in more than 20 countries, with major operations in the UK, Mainland Europe, the USA and Asia-Pacific. We target global niche markets where sustainable growth and high returns are supported by long-term drivers. Halma is listed on the London Stock Exchange and has been a member of the FTSE 100 index since December 2017.

 

Notes

 

1. Adjusted profit before tax is before amortisation and impairment of acquired intangible assets, acquisition items, restructuring costs and profit or loss on disposal of businesses.

 

2. This Trading Update is based upon current management accounts information. Forward-looking statements have been made by the Directors in good faith using information available up until the date that they approved this statement. Forward-looking statements should be regarded with caution because of the inherent uncertainties in economic trends and business risks, including the effects of the current COVID-19 outbreak.

 

3. A copy of this announcement, together with other information about Halma, may be viewed on our website www.halma.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTSEEFMEESSEDU
Date   Source Headline
14th May 201210:55 amRNSHolding(s) in Company
11th May 20123:15 pmRNSHolding(s) in Company
2nd May 20123:48 pmRNSTotal Voting Rights
1st May 20126:22 pmRNSTreasury Stock
2nd Apr 201210:20 amRNSTotal Voting Rights
1st Mar 201210:24 amRNSTotal Voting Rights
28th Feb 20127:00 amRNSChange of Adviser
23rd Feb 20122:15 pmRNSDirector/PDMR Shareholding
21st Feb 20123:08 pmRNSAdditional Listing
16th Feb 20127:00 amRNSInterim Management Statement
10th Feb 20129:38 amRNSTreasury Stock
9th Feb 201211:33 amRNSTreasury Stock
8th Feb 201210:32 amRNSTreasury Stock
3rd Feb 201212:22 pmRNSTreasury Stock
2nd Feb 20122:56 pmRNSTotal Voting Rights
24th Jan 20124:42 pmRNSBlocklisting Interim Review
3rd Jan 20124:57 pmRNSTotal Voting Rights
1st Dec 20114:40 pmRNSTotal Voting Rights
22nd Nov 20112:25 pmRNSDoc re. Half Year Report 2011/12
22nd Nov 20117:00 amRNSHalf Yearly Report
21st Nov 201111:08 amRNSDirector Declaration
14th Nov 20113:46 pmRNSHolding(s) in Company
14th Nov 20113:44 pmRNSNotice of Results
11th Nov 20117:00 amRNSDirectorate Change
2nd Nov 201112:56 pmRNSDirector Declaration
1st Nov 201111:12 amRNSTotal Voting Rights
17th Oct 20114:06 pmRNSHolding(s) in Company
11th Oct 20113:35 pmRNSHolding(s) in Company
6th Oct 20112:54 pmRNSDirector/PDMR Shareholding
3rd Oct 201110:41 amRNSTotal Voting Rights
15th Sep 201112:47 pmRNSDirector/PDMR Shareholding
1st Sep 201112:47 pmRNSTotal Voting Rights
26th Aug 20112:32 pmRNSBlocklisting Interim Review
16th Aug 20115:19 pmRNSAnnual Information Update
12th Aug 20114:43 pmRNSShare transactions and Purchase of Own Shares
8th Aug 201112:48 pmRNSTreasury Stock
1st Aug 20112:40 pmRNSTotal Voting Rights
29th Jul 20112:10 pmRNSDirectorate Change
29th Jul 20111:20 pmRNSResult of AGM
28th Jul 20117:00 amRNSAGM Statement
12th Jul 201110:13 amRNSDirector/PDMR Shareholding
11th Jul 20119:25 amRNSAcquisition
1st Jul 201111:55 amRNSTotal Voting Rights
28th Jun 20114:06 pmRNSDirector/PDMR Shareholding
27th Jun 201112:45 pmRNSAnnual Financial Report
21st Jun 20117:00 amRNSFinal Results
14th Jun 20119:24 amRNSNotice of Results
2nd Jun 201111:51 amRNSTotal Voting Rights
10th May 20119:00 amRNSAcquisition
5th May 201112:01 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.